Click on a filter below to refine your search. Remove a filter to broaden your search.
Vascular and neurodegenerative injuries are approximately equally responsible for cognitive impairment.
Readmission rates were highest for those with frailty and probable dementia.
No significant association was seen for lesser durations of proton pump inhibitor use.
Dementia rates, however, were lower than a comparison cohort of people with Parkinson’s disease.
Findings were similar across races, but Black individuals more often attended the lowest educational quality schools.
Sulfonylurea monotherapy was linked to increased risk for all-cause dementia compared with metformin monotherapy.
No such association was seen for Black older adults followed for 15 years, regardless of sleep duration.
The findings were seen among US adults irrespective of overall diet quality.
The findings were seen among middle-aged and older adults without cognitive impairment or Parkinson’s disease at baseline.
Women with atrial fibrillation and normal baseline cognition had higher risk of disease progression from normal to MCI, MCI to dementia